IL159281A0 - Process for the production of n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon) - Google Patents

Process for the production of n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon)

Info

Publication number
IL159281A0
IL159281A0 IL15928102A IL15928102A IL159281A0 IL 159281 A0 IL159281 A0 IL 159281A0 IL 15928102 A IL15928102 A IL 15928102A IL 15928102 A IL15928102 A IL 15928102A IL 159281 A0 IL159281 A0 IL 159281A0
Authority
IL
Israel
Prior art keywords
cyanopyrazolo
zaleplon
ethylacetamide
pyrimidin
phenyl
Prior art date
Application number
IL15928102A
Other languages
English (en)
Original Assignee
Biogal Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Pharmaceutical Co Ltd filed Critical Biogal Pharmaceutical Co Ltd
Publication of IL159281A0 publication Critical patent/IL159281A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL15928102A 2001-06-12 2002-06-12 Process for the production of n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon) IL159281A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29763501P 2001-06-12 2001-06-12
PCT/US2002/018567 WO2002100828A2 (en) 2001-06-12 2002-06-12 Process for the production of zaleplon

Publications (1)

Publication Number Publication Date
IL159281A0 true IL159281A0 (en) 2004-06-01

Family

ID=23147125

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15928102A IL159281A0 (en) 2001-06-12 2002-06-12 Process for the production of n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon)

Country Status (20)

Country Link
US (2) US6884888B2 (pl)
EP (1) EP1406871A4 (pl)
JP (1) JP2005507858A (pl)
KR (1) KR20040007683A (pl)
CN (1) CN1537113A (pl)
CA (1) CA2450384A1 (pl)
CZ (1) CZ20033544A3 (pl)
DE (1) DE02778962T1 (pl)
ES (1) ES2223311T1 (pl)
HR (1) HRP20040016A2 (pl)
HU (1) HUP0402257A2 (pl)
IL (1) IL159281A0 (pl)
IS (1) IS7069A (pl)
MX (1) MXPA03011485A (pl)
NO (1) NO20035538D0 (pl)
PL (1) PL372942A1 (pl)
SK (1) SK16232003A3 (pl)
TR (1) TR200402588T3 (pl)
WO (1) WO2002100828A2 (pl)
ZA (1) ZA200309677B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032818A1 (en) * 2001-06-12 2005-02-10 Entire Interest N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
PL372942A1 (pl) * 2001-06-12 2005-08-08 Biogal Gyogyszergyar Rt Sposób wytwarzania N-[3-(3-cyjanopirazolo [1,5-A]pirymidyn-7-ylo) fenylo]-N-etyloacetamidu (zaleplonu)
IL160076A0 (en) * 2001-08-01 2004-06-20 Biogal Gyogyszergyar Process for purifying n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process
WO2003068238A1 (en) * 2002-02-15 2003-08-21 Biogal Gyogyszergyar Rt. Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
PL207322B1 (pl) * 2002-05-14 2010-11-30 Adamed Społka Z Ograniczoną Odpowiedzialnością Sposób wytwarzania zaleplonu
AU2002343201A1 (en) * 2002-10-16 2004-05-04 Sanmar Speciality Chemicals Limited Synthesis of zaleplon
CZ20023575A3 (cs) * 2002-10-25 2004-01-14 Léčiva, A.S. Způsob výroby N-ethyl-N-[3-(3-methyl-pyrazolo[1,5-a]pyrimidin-7-yl)-fenyl]-acetamidu (zaleplonu)
KR101248123B1 (ko) * 2003-09-04 2013-03-27 씨아이피엘에이 엘티디. 잘레플론의 합성
DE602004025747D1 (de) * 2004-01-14 2010-04-08 Mallinckrodt Inc Zweiphasiges verfahren zur synthese ausgewählter pyrazolopyrimidine
HUP0400325A3 (en) 2004-02-02 2005-11-28 Richter Gedeon Vegyeszet Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates
WO2005099712A2 (en) * 2004-04-19 2005-10-27 Sanmar Speciality Chemicals Limited Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide
WO2006070244A2 (en) * 2004-11-22 2006-07-06 Bakulesh Mafatlal Khamar A process for the preparation of zaleplon
CN102816163A (zh) * 2012-08-20 2012-12-12 四川禾邦阳光制药股份有限公司 扎来普隆的新晶型及制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US5714607A (en) * 1995-12-01 1998-02-03 American Cyanamid Company Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
US6485746B1 (en) * 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
AU2001283119B2 (en) * 2000-08-03 2007-11-15 Wyeth Polymorphs of zaleplon and methods for the preparation thereof
AR029780A1 (es) * 2000-12-13 2003-07-16 Gador Sa Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida
PL372942A1 (pl) * 2001-06-12 2005-08-08 Biogal Gyogyszergyar Rt Sposób wytwarzania N-[3-(3-cyjanopirazolo [1,5-A]pirymidyn-7-ylo) fenylo]-N-etyloacetamidu (zaleplonu)
IL160076A0 (en) * 2001-08-01 2004-06-20 Biogal Gyogyszergyar Process for purifying n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process
PL207322B1 (pl) * 2002-05-14 2010-11-30 Adamed Społka Z Ograniczoną Odpowiedzialnością Sposób wytwarzania zaleplonu

Also Published As

Publication number Publication date
US20030040522A1 (en) 2003-02-27
MXPA03011485A (es) 2004-06-11
EP1406871A2 (en) 2004-04-14
WO2002100828A2 (en) 2002-12-19
SK16232003A3 (sk) 2004-12-01
EP1406871A4 (en) 2005-01-26
ZA200309677B (en) 2004-12-13
TR200402588T3 (tr) 2004-11-22
DE02778962T1 (de) 2005-02-10
WO2002100828A3 (en) 2003-05-01
HUP0402257A2 (hu) 2005-02-28
PL372942A1 (pl) 2005-08-08
US20050187225A1 (en) 2005-08-25
CZ20033544A3 (cs) 2004-11-10
US6884888B2 (en) 2005-04-26
CA2450384A1 (en) 2002-12-19
CN1537113A (zh) 2004-10-13
KR20040007683A (ko) 2004-01-24
JP2005507858A (ja) 2005-03-24
ES2223311T1 (es) 2005-03-01
HRP20040016A2 (en) 2004-10-31
NO20035538D0 (no) 2003-12-11
IS7069A (is) 2003-12-10

Similar Documents

Publication Publication Date Title
IL159281A0 (en) Process for the production of n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon)
AU2002329994A1 (en) Process for the synthesis of pyrazolopyrimidines
NO307181B1 (no) Fremgangsmåte for fremstilling av N-[3(3-cyanopyrazol[1,5- a]pyrimidin-7-yl)fenyl]-N-etylacetamid
PT1674456E (pt) Utilização de 2-fluoro-3-cetoésteres para preparar 3-fluoro- 6,7,8,9-tetra-hidro-4-h-pirimido[1,2-a]pirimidin-4-onas
IL160076A0 (en) Process for purifying n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process
IL144516A0 (en) PROCESS FOR THE PREPARATION OF PYRAZOLO [4,3-d] PYRIMIDIN-7-ONE COMPOUNDS AND INTERMEDIATES THEREOF
TWI340140B (en) N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides and compositions and methods related thereto
WO2002012244A3 (en) Polymorphs of zaleplon and methods for the preparation thereof
IL175753A0 (en) PROCESSES FOR THE PREPARATION OF PYRAZOLO [1,5-a]-1,3,5-TRIAZINES AND INTERMEDIATES THEREOF
EG22775A (en) Process for the preparation of pyrazolo (f,5-d) pyrimidin 7 ones-3-pyridylsulphonyl compounds and intermediates thereof
IL165895A0 (en) Process for the preparation of phenyl pyrazole compounds
ATE269082T1 (de) Polymorphe des n-methyl-n-(3-(2-thienylcarbonyl)- pyrazol(1,5-a)pyrimidin-7-yl phenyl)acetamid und zusammenstellungen und diesbezügliche methoden
IL177856A0 (en) 2-pyridinyl[7-(substituted-pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
HUP0400325A3 (en) Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates
PL374911A1 (pl) Sposób wytwarzania zaleplonu
IL176471A0 (en) Process for the preparation of triazolopyrimidines
WO2006070244A3 (en) A process for the preparation of zaleplon
GB0107526D0 (en) Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-one compounds and intermediates thereof
GB0110251D0 (en) Process for the preparation of pyrazolo[4,4-d]Pyrimidin-7-one compounds and intermediates thereof
ZA200106161B (en) Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof.
PL335635A1 (en) Method of obtaining 5-[2-ethoxy-5-(4-methylpiperazin-1-ylsulphonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7-h-pyrazole[4,3-d]-pyrimidyn-7-one
PL372304A1 (pl) Sposób wytwarzania immunosupresora
GB0105857D0 (en) Novel process for the preparation of pyrazolopyrimidinones
MA26810A1 (fr) Procede de preparation de (1,4) diazepino (6,7,1-hi) indol-4-ones substituees
PL337788A1 (en) Method of obtaining 1-{[3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazole[3,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulphonyl}-4-methylpiperazine